Federal False Claims Act Wrap Up (September 2020)
This week we take look at two recent federal decisions concerning the False Claims Act (“FCA”).
The first case, Ndoromo v. Barr, is interesting because of the billion dollars in alleged damages.
In this case out of the U.S. District Court for the District of Columbia, the pro se plaintiff sued various government officials, including the United States Attorney General, for over $1 billion dollars in damages. In separate, prior proceedings, the plaintiff was convicted of various criminal charges, including healthcare fraud. That conviction resulted in the government’s seizure of plaintiff’s funds and personal property in a civil forfeiture action. In response, the plaintiff sued the government and alleged, among other things, that the government violated the False Claims Act. The judge promptly dismissed the claim, noting that the FCA is supposed to be used to “ensure that funds are not falsely taken from the government”, not the other way around. Ndoromo v. Barr, 2020 --- F.Supp.3d ----, 2020 WL 5107546 (U.S.D.C. D.C., August 31, 2020).
The lesson? The only lesson from this case is that perhaps the pro se plaintiff should have retained counsel.
The second case, United States ex rel. Olhausen v. Arriva Medical, LLC, involves a more garden variety dismissal, but makes some interesting distinctions with regard to an “insider” relator’s pleading obligations:
In this case, the Southern District of Florida considered and granted a motion to dismiss on all counts of the relator’s complaint. The relator, a company insider, made multiple allegations of FCA violations against a diabetic supplies and medical products company. Several of the counts were dismissed under a first to file analysis, but the balance were dismissed due to the lack of particularity in the pleadings. One of the missing elements – and an important one in the Court’s view – was the relator’s failure to allege the submission of an actual claim to the government. The relator relied upon 11th Circuit authority, which has relaxed somewhat the “indicia of reliability” standard if the relator has first-hand and direct knowledge of the submission of claims to the government. The relator argued he had direct knowledge of the filing of claims by virtue of his high level position with the company. The Court held that just wasn’t enough. The relator failed to “meaningfully aid the Court in its search for ‘indicia of reliability’” that a false claim actually was submitted to the government. United States ex rel. Olhausen v. Arriva Medical, LLC, --- F.Supp.3d ---- 2020 WL 5077170 (U.S.D.C. S.D. Fl., August 27, 2020).
The lesson? Even if you are an insider, make sure you have facts to support the submission of claims to the government.
Any opinions expressed and any legal positions asserted in the article are those of the author(s) and do not necessarily reflect the opinions or positions of Miles & Stockbridge P.C. or its other lawyers. This article is for general information purposes and is not intended to be and should not be taken as legal advice on any particular matter. It is not intended to and does not create any attorney-client relationship. Because legal advice must vary with individual circumstances, do not act or refrain from acting on the basis of this article without consulting professional legal counsel. If you would like additional information on the subject matter of this article, please feel free to contact any of the lawyers listed above. If you communicate with us, whether through email or other means, your communication does not establish an attorney-client relationship with either Miles & Stockbridge P.C. or any of the firm's lawyers. At Miles & Stockbridge P.C., an attorney-client relationship can be formed only by personal contact with an individual lawyer, not by email, and requires our agreement to act as your legal counsel together with your execution of a written engagement agreement with Miles & Stockbridge P.C.
